Table of Content



1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Key Drivers
3.1.1. Rise In The Incidence Of Gastrointestinal Ailments
3.1.2. Growing Number Of Drug Developments And Fda Approvals
3.1.3. Surging Occurence Of Irritable Bowel Syndrome
3.1.4. Increasing Geriatric Population
3.2. Key Restraints
3.2.1. High Cost Of Drugs
3.2.2. Lack Of Skilled Professionals In Developing Economies
3.2.3. Limited Treatment Options

4. Key Analytics
4.1. Porter’S Five Forces Analysis
4.1.1. Threat Of New Entry
4.1.2. Threat Of Substitution
4.1.3. Buyer’S Power
4.1.4. Supplier’S Power
4.1.5. Competitive Rivalry
4.2. Impact Of Covid-19 On Irritable Bowel Syndrome Treatment Market
4.3. Opportunity Matrix
4.4. Vendor Landscape
4.5. Key Investment Insights

5. Market By Type
5.1. Ibs With Diarrhea
5.2. Ibs With Constipation
5.3. Mixed Ibs

6. Market By Product
6.1. Rifaximin
6.2. Eluxadoline
6.3. Linaclotide
6.4. Lubiprostone
6.5. Other Products

7. Market By Distribution Channel
7.1. Drug Stores And Retail Pharmacies
7.2. Hospitals’ Pharmacies
7.3. Online Pharmacies

8. Market By Mechanism Of Action
8.1. 5Ht3 Antagonist
8.2. Guanylate Cyclase Receptor-C Agonist
8.3. Chloride Channel Activator
8.4. Other Mechanism Of Actions

9. Market By Dosage
9.1. Solid
9.2. Liquid

10. Geographical Analysis
10.1. North America
10.1.1. Market Size & Estimates
10.1.2. Key Growth Enablers
10.1.3. Key Challenges
10.1.4. Key Players
10.1.5. Country Analysis
10.1.5.1. United States
10.1.5.2. Canada
10.2. Europe
10.2.1. Market Size & Estimates
10.2.2. Key Growth Enablers
10.2.3. Key Challenges
10.2.4. Key Players
10.2.5. Country Analysis
10.2.5.1. Germany
10.2.5.2. France
10.2.5.3. United Kingdom
10.2.5.4. Italy
10.2.5.5. Russia
10.2.5.6. Belgium
10.2.5.7. Poland
10.2.5.8. Rest Of Europe
10.3. Asia Pacific
10.3.1. Market Size & Estimates
10.3.2. Key Growth Enablers
10.3.3. Key Challenges
10.3.4. Key Players
10.3.5. Country Analysis
10.3.5.1. Japan
10.3.5.2. China
10.3.5.3. Australia & New Zealand
10.3.5.4. India
10.3.5.5. South Korea
10.3.5.6. Thailand
10.3.5.7. Indonesia
10.3.5.8. Vietnam
10.3.5.9. Rest Of Asia Pacific
10.4. Rest Of World
10.4.1. Market Size & Estimates
10.4.2. Key Growth Enablers
10.4.3. Key Challenge
10.4.4. Key Players
10.4.5. Regional Analysis
10.4.5.1. Latin America
10.4.5.2. Middle East & Africa

11. Competitive Landscape
11.1. Key Strategic Developments
11.1.1. Merger & Acquisitions
11.1.2. Product Launch & Developments
11.1.3. Partnership, Contract/Agreement & Collaboration
11.1.4. Business Expansion/ Approval/ Announcement
11.2. Company Profile
11.2.1. Abbott Laboratories
11.2.2. Bausch Health Companies Inc
11.2.3. Allergan Plc
11.2.4. Ardelyx Inc
11.2.5. Astellas Pharma Inc
11.2.6. Astrazeneca Plc
11.2.7. Glaxosmithkline Plc
11.2.8. Ironwood Pharmaceuticals Inc
11.2.9. Johnson & Johnson (Mcneil Consumer Healthcare)
11.2.10. Lannett Company Inc
11.2.11. Novartis Ag
11.2.12. Sebela Pharmaceuticals Inc
11.2.13. Synthetic Biologics Inc
11.2.14. Takeda Pharmaceutical Company Ltd



List of Figures


Figure 1: Porter’S Five Force Analysis
Figure 2: Opportunity Matrix
Figure 3: Vendor Landscape
Figure 4: Key Investment Insights
Figure 5: Global Irritable Bowel Syndrome Treatment Market, By Type, In 2020
Figure 6: Global Irritable Bowel Syndrome Treatment Market, By Ibs With Diarrhea, 2021-2028 (In $ Million)
Figure 7: Global Irritable Bowel Syndrome Treatment Market, By Ibs With Constipation, 2021-2028 (In $ Million)
Figure 8: Global Irritable Bowel Syndrome Treatment Market, By Mixed Ibs, 2021-2028 (In $ Million)
Figure 9: Global Irritable Bowel Syndrome Treatment Market, By Product, In 2020
Figure 10: Global Irritable Bowel Syndrome Treatment Market, By Rifaximin, 2021-2028 (In $ Million)
Figure 11: Global Irritable Bowel Syndrome Treatment Market, By Eluxadoline, 2021-2028 (In $ Million)
Figure 12: Global Irritable Bowel Syndrome Treatment Market, By Linaclotide, 2021-2028 (In $ Million)
Figure 13: Global Irritable Bowel Syndrome Treatment Market, By Lubiprostone, 2021-2028 (In $ Million)
Figure 14: Global Irritable Bowel Syndrome Treatment Market, By Other Products, 2021-2028 (In $ Million)
Figure 15: Global Irritable Bowel Syndrome Treatment Market, By Distribution Channel, In 2020
Figure 16: Global Irritable Bowel Syndrome Treatment Market, By Drug Stores And Retail Pharmacies, 2021-2028 (In $ Million)
Figure 17: Global Irritable Bowel Syndrome Treatment Market, By Hospitals’ Pharmacies, 2021-2028 (In $ Million)
Figure 18: Global Irritable Bowel Syndrome Treatment Market, By Online Pharmacies, 2021-2028 (In $ Million)
Figure 19: Global Irritable Bowel Syndrome Treatment Market, By Mechanism Of Action, In 2020
Figure 20: Global Irritable Bowel Syndrome Treatment Market, By 5Ht3 Antagonist, 2021-2028 (In $ Million)
Figure 21: Global Irritable Bowel Syndrome Treatment Market, By Guanylate Cyclase Receptor-C Agonist, 2021-2028 (In $ Million)
Figure 22: Global Irritable Bowel Syndrome Treatment Market, By Chloride Channel Activator, 2021-2028 (In $ Million)
Figure 23: Global Irritable Bowel Syndrome Treatment Market, By Other Mechanism Of Actions, 2021-2028 (In $ Million)
Figure 24: Global Irritable Bowel Syndrome Treatment Market, By Dosage, In 2020
Figure 25: Global Irritable Bowel Syndrome Treatment Market, By Solid, 2021-2028 (In $ Million)
Figure 26: Global Irritable Bowel Syndrome Treatment Market, By Liquid, 2021-2028 (In $ Million)
Figure 27: North America Irritable Bowel Syndrome Treatment Market, Country Outlook, 2020 & 2028 (In %)
Figure 28: United States Irritable Bowel Syndrome Treatment Market, 2021-2028 (In $ Million)
Figure 29: Canada Irritable Bowel Syndrome Treatment Market, 2021-2028 (In $ Million)
Figure 30: Europe Irritable Bowel Syndrome Treatment Market, Country Outlook, 2020 & 2028 (In %)
Figure 31: Germany Irritable Bowel Syndrome Treatment Market, 2021-2028 (In $ Million)
Figure 32: France Irritable Bowel Syndrome Treatment Market, 2021-2028 (In $ Million)
Figure 33: United Kingdom Irritable Bowel Syndrome Treatment Market, 2021-2028 (In $ Million)
Figure 34: Italy Irritable Bowel Syndrome Treatment Market, 2021-2028 (In $ Million)
Figure 35: Russia Irritable Bowel Syndrome Treatment Market, 2021-2028 (In $ Million)
Figure 36: Belgium Irritable Bowel Syndrome Treatment Market, 2021-2028 (In $ Million)
Figure 37: Poland Irritable Bowel Syndrome Treatment Market, 2021-2028 (In $ Million)
Figure 38: Rest Of Europe Irritable Bowel Syndrome Treatment Market, 2021-2028 (In $ Million)
Figure 39: Asia Pacific Irritable Bowel Syndrome Treatment Market, Country Outlook, 2020 & 2028 (In %)
Figure 40: Japan Irritable Bowel Syndrome Treatment Market, 2021-2028 (In $ Million)
Figure 41: China Irritable Bowel Syndrome Treatment Market, 2021-2028 (In $ Million)
Figure 42: Australia & New Zealand Irritable Bowel Syndrome Treatment Market, 2021-2028 (In $ Million)
Figure 43: India Irritable Bowel Syndrome Treatment Market, 2021-2028 (In $ Million)
Figure 44: South Korea Irritable Bowel Syndrome Treatment Market, 2021-2028 (In $ Million)
Figure 45: Thailand Irritable Bowel Syndrome Treatment Market, 2021-2028 (In $ Million)
Figure 46: Indonesia Irritable Bowel Syndrome Treatment Market, 2021-2028 (In $ Million)
Figure 47: Vietnam Irritable Bowel Syndrome Treatment Market, 2021-2028 (In $ Million)
Figure 48: Rest Of Asia Pacific Irritable Bowel Syndrome Treatment Market, 2021-2028 (In $ Million)
Figure 49: Rest Of World Irritable Bowel Syndrome Treatment Market, Regional Outlook, 2020 & 2028 (In %)
Figure 50: Latin America Irritable Bowel Syndrome Treatment Market, 2021-2028 (In $ Million)
Figure 51: Middle East & Africa Irritable Bowel Syndrome Treatment Market, 2021-2028 (In $ Million)


List of Tables


List of Tables


TABLE 1: MARKET SNAPSHOT - IRRITABLE BOWEL SYNDROME TREATMENT
TABLE 2: NUMBER OF PERSONS AGED 65 YEARS OR OVER BY GEOGRAPHIC REGION, 2019 AND 2050
TABLE 3: GLOBAL IRRITABLE BOWEL SYNDROME TREATMENT MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 4: GLOBAL IRRITABLE BOWEL SYNDROME TREATMENT MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 5: GLOBAL IBS WITH DIARRHEA MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 6: GLOBAL IBS WITH DIARRHEA MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 7: GLOBAL IBS WITH CONSTIPATION MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 8: GLOBAL IBS WITH CONSTIPATION MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 9: GLOBAL MIXED IBS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 10: GLOBAL MIXED IBS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 11: GLOBAL IRRITABLE BOWEL SYNDROME TREATMENT MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 12: GLOBAL IRRITABLE BOWEL SYNDROME TREATMENT MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 13: GLOBAL RIFAXIMIN MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 14: GLOBAL RIFAXIMIN MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 15: GLOBAL ELUXADOLINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 16: GLOBAL ELUXADOLINE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 17: GLOBAL LINACLOTIDE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 18: GLOBAL LINACLOTIDE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 19: GLOBAL LUBIPROSTONE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 20: GLOBAL LUBIPROSTONE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 21: GLOBAL OTHER PRODUCTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 22: GLOBAL OTHER PRODUCTS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 23: GLOBAL IRRITABLE BOWEL SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 24: GLOBAL IRRITABLE BOWEL SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 25: GLOBAL DRUG STORES AND RETAIL PHARMACIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 26: GLOBAL DRUG STORES AND RETAIL PHARMACIES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 27: GLOBAL HOSPITALS’ PHARMACIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 28: GLOBAL HOSPITALS’ PHARMACIES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 29: GLOBAL ONLINE PHARMACIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 30: GLOBAL ONLINE PHARMACIES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 31: GLOBAL IRRITABLE BOWEL SYNDROME TREATMENT MARKET, BY MECHANISM OF ACTION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 32: GLOBAL IRRITABLE BOWEL SYNDROME TREATMENT MARKET, BY MECHANISM OF ACTION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 33: GLOBAL 5HT3 ANTAGONIST MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 34: GLOBAL 5HT3 ANTAGONIST MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 35: GLOBAL GUANYLATE CYCLASE RECEPTOR-C AGONIST MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 36: GLOBAL GUANYLATE CYCLASE RECEPTOR-C AGONIST MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 37: GLOBAL CHLORIDE CHANNEL ACTIVATOR MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 38: GLOBAL CHLORIDE CHANNEL ACTIVATOR MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 39: GLOBAL OTHER MECHANISM OF ACTIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 40: GLOBAL OTHER MECHANISM OF ACTIONS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 41: GLOBAL IRRITABLE BOWEL SYNDROME TREATMENT MARKET, BY DOSAGE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 42: GLOBAL IRRITABLE BOWEL SYNDROME TREATMENT MARKET, BY DOSAGE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 43: GLOBAL SOLID MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 44: GLOBAL SOLID MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 45: GLOBAL LIQUID MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 46: GLOBAL LIQUID MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 47: GLOBAL IRRITABLE BOWEL SYNDROME TREATMENT MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 48: GLOBAL IRRITABLE BOWEL SYNDROME TREATMENT MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 49: NORTH AMERICA IRRITABLE BOWEL SYNDROME TREATMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 50: NORTH AMERICA IRRITABLE BOWEL SYNDROME TREATMENT MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 51: LEADING PLAYERS OPERATING IN NORTH AMERICA IRRITABLE BOWEL SYNDROME TREATMENT MARKET
TABLE 52: EUROPE IRRITABLE BOWEL SYNDROME TREATMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 53: EUROPE IRRITABLE BOWEL SYNDROME TREATMENT MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 54: LEADING PLAYERS OPERATING IN EUROPE IRRITABLE BOWEL SYNDROME TREATMENT MARKET
TABLE 55: ASIA PACIFIC IRRITABLE BOWEL SYNDROME TREATMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 56: ASIA PACIFIC IRRITABLE BOWEL SYNDROME TREATMENT MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 57: LEADING PLAYERS OPERATING IN ASIA PACIFIC IRRITABLE BOWEL SYNDROME TREATMENT MARKET
TABLE 58: REST OF WORLD IRRITABLE BOWEL SYNDROME TREATMENT MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 59: REST OF WORLD IRRITABLE BOWEL SYNDROME TREATMENT MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 60: LEADING PLAYERS OPERATING IN REST OF WORLD IRRITABLE BOWEL SYNDROME TREATMENT MARKET